Navigation Links
Solve Skin Conditions and Receive Hair Loss Treatment from Home with New Line of Medical Devices Called Dermaray
Date:8/30/2009

Using state-of-the-art phototherapy technology, Dermaray UV can minimize the effects from skin conditions, while the Dermaray Laser is designed to be a leading home hair loss treatment solution.

(PRWEB) August 30, 2009 -- TCG Industrial Australia, a leader in providing solutions for skin conditions and hair loss treatment options, are pleased to announce the introduction of the Dermaray range of home phototherapy medical devices.

Dermaray systems are designed, constructed and tested in Australia under ISO international quality control standards and supplied with an industry first transferable two year factory warranty. All Dermaray systems feature a unique safety proximity detection system that is able to activate and deactivate the system if unsafe usage is detected providing unparalleled safety to the user.

Dermaray UV is a narrow band UVB-311nm hand held, battery operated and computer controlled medical device for the treatment of chronic skin conditions such as psoriasis, vitiligo, acne and atopic dermatitis. It boasts many unique safety features, plus an innovative and intuitive computer operating system that calculates and manages up to 10 individual patients with up to 32 treatment areas in each treatment program.

Psoriasis is a chronic, non-contagious autoimmune disease which affects the skin and joints. It commonly causes red scaly patches to appear on the skin. UVB has been used to treat psoriasis for more than 75 years. UVB has been the phototherapy of choice for psoriasis since it was found to be less carcinogenic than UVA and since the development in the late 1980s of a highly efficacious UVB lamp, termed narrow band UVB in the 311nm range.

Vitiligo is a pigmentation disorder, characterised by white patches on the skin. Vitiligo has proven to respond exceptionally well to treatment with Dermaray UV with approximately 80% of patients experiencing an 80% reduction in their condition.

Dermaray Laser is a 100mW red medical laser based on 660nm technology. The Dermaray Laser Low Level Laser Therapy (LLLT) system represents the finest quality and most technologically advanced hand held laser system available today. Unique patent pending technology allows the advanced application of more powerful medical laser modules while offering safety features unique to Dermaray Laser that prevent accidental exposure to the visible laser energy.

Dermaray Laser is designed to be a leading home hair loss treatment solution, wound regeneration, wrinkle and scar reduction and physiotherapy. Low Level Laser Therapy has been proven safe and effective between 1~500mW. Other laser combs and laser brushes are based on 1-5mW lasers that are typically found in laser pointers and video game accessories. Laws of physics dictate that to deliver the required amount of energy required for measurable medical results quickly and efficiently over the scalp, stronger lasers are required as used in Dermaray Laser systems.

Dermaray UV sells for $695 USD and Dermaray Laser for $895 USD.
More information on the Dermaray UV for skin conditions or the hair loss treatment solution Dermaray Laser is available from Nick Balgowan at TCG Industrial, Unit 3, 6 Barnett Court, Morley, WA 6062 Australia. Telephone: (+61) 8 9370 4038 or web: www.dermaray.com

Contact
Nick Balgowan
(+61) 8 9370 4038

###

Read the full story at http://www.prweb.com/releases/dermaray_tcg/hair_loss_treatment/prweb2795534.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Mother and Daughter Create Lead-Free/Safe Bibs and Solve Messy Mealtime Problems
2. MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
3. Tips for Parents: Teaching Children to Resolve Conflicts
4. Lipodissolve - Is it Safe???
5. Higher-risk kidneys may help solve organ shortage facing older adults
6. ULLICO Inc. and U.S. Department of Labor Agree to Resolve 5 Year Old ERISA Investigation
7. Will Lipodissolve Continue to Remain Popular?
8. American Society for Aesthetic Plastic Surgery and American Society of Plastic Surgeons Offer Patient Advisory for those Affected by Fig LipoDissolve Closures
9. Manor Care Files Motion with West Virginia Health Care Authority to Dissolve Stay and Issue an Immediate Ruling
10. Researchers solve first structure of a key to intact DNA inheritance
11. Industrial Solvent May Increase Risk for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Solve Skin Conditions and Receive Hair Loss Treatment from Home with New Line of Medical Devices Called Dermaray
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer ... they remain in the eye of the beholder, according to experts who offered insights ... American Journal of Managed Care. For the full issue, click here . , ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas is ...
Breaking Medicine Technology: